Cleared Traditional

K252458 - Kyphoplasty Balloon Dilatation Catheters

K252458 is an FDA 510(k) clearance for Kyphoplasty Balloon Dilatation Catheters, manufactured by Shanghai Lange Medtech Co., Ltd.. The device is a Class 2 Orthopedic device with product code HRX cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K252458 · Shanghai Lange Medtech Co., Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2025
Decision
90d
Days
Class 2
Risk

K252458 is an FDA 510(k) clearance for the Kyphoplasty Balloon Dilatation Catheters. Classified as Arthroscope (product code HRX), Class II - Special Controls.

Submitted by Shanghai Lange Medtech Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on November 3, 2025 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.1100 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai Lange Medtech Co., Ltd. devices

FDA 510(k) Submission Details - K252458

510(k) Number K252458 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 05, 2025
Decision Date November 03, 2025
Days to Decision 90 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 122d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HRX Device Classification - Class 2, Special Controls

Product Code HRX Arthroscope
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.1100
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Consultant

Shanghai Mil-Medshare Medical Technology Co., Ltd.
Chen Kevin

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - HRX Arthroscope

All 407
Devices cleared under the same product code (HRX) and FDA review panel - the closest regulatory comparables to K252458.
MiiS Horus Arthroscope (EJA 100)
K253217 · Medimaging Integrated Solution, Inc (Miis) · Dec 2025
PUREVUE™ FMS
K250795 · W.O.M. World of Medicine GmbH · Dec 2025
Articulator Arthroscopic Bur
K252666 · Joint Preservation Innovations, LLC · Nov 2025
TunnelVision Endoscopic Soft Tissue Release System and the HBL Blade Assembly
K252020 · Hand Biomechanics Lab, Inc. · Oct 2025
UltraGuideCTR® image guided soft tissue release system
K252594 · Sonex Health · Sep 2025
ELID (Endoscopic Less Invasive Decompression) System
K243774 · Lesspine Innovations · Aug 2025